HSD17B13-IN-26
HSD17B13-IN-26 (Compound 18.04) is an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) . HSD17B13-IN-26 can be used in the research of liver diseases such as hepatitis, liver fibrosis, liver cirrhosis, and hepatocellular carcinoma[1].
Product Specifications
CAS Number
[2919797-61-6]
UNSPSC
12352005
Target
17β-HSD
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/hsd17b13-in-26.html
Solubility
10 mM in DMSO
Smiles
CC(C)CC1CN(CCN1C2=NC3=C(C(C4=CC(C(F)(F)F)=C(C(O)=C4F)F)=NN3C)C=N2)S(C)(=O)=O
Molecular Formula
C22H25F5N6O3S
Molecular Weight
548.53
References & Citations
[1]Johnny Y. Nagasawa, et al. Hsd17b13 inhibitors and uses thereof. WIPO, WO2023043836A1. 2023-03-23.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GGA1 (ADP-ribosylation Factor-binding Protein GGA1, Gamma-adaptin-related Protein 1, Golgi-localized, gamma Ear-containing, ARF-binding Protein 1)